Glioblastoma: open trials in South Korea

7 open trials have a site in South Korea. Registry data; only the trial team decides who can take part.

NCT07831161
Safety and Efficacy of Autologous Natural Killer Cell Therapy (CHANK-101) in Patients With Recurrent Glioblastoma
Trial Treatment · Dong-A University Hospital
Dong-A University Hospital, Busan · CHA Bundang Medical Center, Seongnam-si · Asan Medical Center, Seoul · Gangnam Severance Hospital, Seoul
Registry updated 2026-11-02
NCT04094610
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Trial Treatment · Phase 1/2 · Turning Point Therapeutics, Inc.
Seoul · Seoul · Seoul National University Hospital, Seoul · Asan Medical Center, Seoul
Registry updated 2026-09-25
NCT07143812
A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma
Trial Treatment · Phase 1 · CHA University
Bundang CHA Medical Center, Seongnam
Registry updated 2026-01-22
NCT06102525
A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma
Trial Treatment · Phase 1/2 · Rznomics, Inc.
The Catholic University of Korea, Incheon St. Mary's Hospital, Incheon · Gachon University Gil Medical Center, Incheon · Seoul National University Bundang Hospital, Seongnam-si · Asan Medical Center, Seoul · Samsung Medical Center, Seoul · Severance Hospital, Yonsei University Health System, Seoul
Registry updated 2025-09-05
NCT05439278
Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma
Trial Treatment · Phase 3 · Severance Hospital
Severance hospital, Seoul
Registry updated 2025-05-21
NCT05769660
A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma Multiforme (GBM)
Trial Treatment · Phase 1 · BeyondBio Inc.
Seoul National University Hospital, Seoul
Registry updated 2025-03-10
NCT06782984
Drug Response Testing and Repurposing Using Glioblastoma Organoid
Research · Chungnam National University Hospital
Chungnam National University Hospital, Daejeon
Registry updated 2025-01-20

All Glioblastoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error

Glioblastoma: open trials in South Korea

Safety and Efficacy of Autologous Natural Killer Cell Therapy (CHANK-101) in Patients With Recurrent Glioblastoma

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma

A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma

Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma

A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma Multiforme (GBM)

Drug Response Testing and Repurposing Using Glioblastoma Organoid